Oil prices rise on talk of Russia sanctions; bouncing off recent lows
Ann Scott Blouin, a director at Ensign Group, Inc. (NASDAQ:ENSG), recently sold 450 shares of the company’s common stock. The shares were sold at a price of $128.06 each, totaling $57,627. The transaction comes as the stock has experienced a notable 13% decline over the past week, though InvestingPro analysis suggests the company remains undervalued relative to its Fair Value. Following the transaction, Blouin holds 21,252 shares in the company. This sale was executed under a pre-established Rule 10b5-1 trading plan, which was adopted on November 12, 2024. With analyst price targets ranging from $155 to $175 and a strong financial health rating, InvestingPro subscribers can access 8 additional key insights about Ensign Group’s valuation and growth prospects.
In other recent news, a series of analyst notes have highlighted the ongoing strength of The Ensign Group . Stephens analyst Scott Fidel raised the stock target to $160, maintaining an Overweight rating, citing the company’s consistent mid-teens compound annual growth rates in revenue and adjusted earnings per share. Fidel also noted the company’s focus on mergers and acquisitions, particularly in emerging geographical markets, and its intent to normalize its acquisition mix towards turnaround opportunities.
Additionally, Macquarie analyst Tao Qiu increased the price target to $166, keeping an Outperform rating. The adjustment comes amid expectations that The Ensign Group will surpass current consensus estimates for 2025, driven by an acceleration in acquisition activity. Qiu projects that the company will achieve revenue growth between 12.5% and 15.0% in 2025, including 5.5% organic growth and an additional 7.0% to 9.5% from acquisitions.
Furthermore, UBS initiated coverage on The Ensign Group with a Buy rating and a price target of $175. The firm recognized the company’s ability to acquire and revitalize underperforming facilities, suggesting ample opportunities for continued growth in the skilled nursing facility sector. These recent developments underscore the company’s potential to leverage the current industry dynamics and continue its trajectory of growth and margin enhancement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.